Federal Agency for Medicines and Health Products (FAMHP) (FAMHP)
Federal Agency for Medicines and Health Products (FAMHP) is the official source of medicine shortage information for Belgium (Europe). Mederti checks its register daily and links every notice back to the original publication.
- Official register
- pharmastatus.be
- Country
- Belgium
- Notices tracked by Mederti
- 1,756
- Last checked
- 24 Sept 2026
Latest notices from FAMHP
- Colistimethate Sodium — active, high, since 12 Oct 2026 (source)
- Hydrochlorothiazide; Olmesartan Medoxomil — active, medium, since 7 Oct 2026 (source)
- Sevelamer — active, medium, since 6 Oct 2026 (source)
- Temocillin — active, medium, since 4 Oct 2026 (source)
- Epoetin Alfa — active, medium, since 4 Oct 2026 (source)
- Propranolol Hydrochloride — active, medium, since 30 Sept 2026 (source)
- Prazepam — active, medium, since 30 Sept 2026 (source)
- Bumetanide — active, medium, since 26 Sept 2026 (source)
- Norepinephrine Bitartrate In — active, medium, since 25 Sept 2026 (source)
- Olmesartan Medoxomil; Amlodipine — active, medium, since 23 Sept 2026 (source)
- Triazolam — active, medium, since 23 Sept 2026 (source)
- Bempedoic Acid; Ezetimibe — active, medium, since 23 Sept 2026 (source)
- Cabergoline — active, medium, since 22 Sept 2026 (source)
- Pemetrexed — active, medium, since 22 Sept 2026 (source)
- Gadobenic Acid — active, medium, since 22 Sept 2026 (source)
Every FAMHP notice, searchable and alertable
Search Belgium's full register alongside 50+ other countries — free for individual pharmacists and clinicians.
Create a free accountMederti is not affiliated with or endorsed by Federal Agency for Medicines and Health Products (FAMHP). All notices remain the property of their publisher and are linked to the original source.